Research ArticleAccepted Article
Rituximab associated vasculitis flare: incidence, predictors and outcome
A.C. Desbois, L. Biard, D Sene, I. Brocheriou, P. Rouvier, B. Lioger, L. Musset, S. Candon, T. Zenone, M. Resche-Rigon, J.C. Piette, N. Benameur, P. Cacoub and D. Saadoun
The Journal of Rheumatology August 2019, jrheum.190076; DOI: https://doi.org/10.3899/jrheum.190076
A.C. Desbois
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
L. Biard
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
D Sene
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
I. Brocheriou
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
P. Rouvier
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
B. Lioger
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
L. Musset
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
S. Candon
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
T. Zenone
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
M. Resche-Rigon
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
J.C. Piette
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
N. Benameur
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
P. Cacoub
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
D. Saadoun
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Rituximab associated vasculitis flare: incidence, predictors and outcome
A.C. Desbois, L. Biard, D Sene, I. Brocheriou, P. Rouvier, B. Lioger, L. Musset, S. Candon, T. Zenone, M. Resche-Rigon, J.C. Piette, N. Benameur, P. Cacoub, D. Saadoun
The Journal of Rheumatology Aug 2019, jrheum.190076; DOI: 10.3899/jrheum.190076
Accepted manuscript
Rituximab associated vasculitis flare: incidence, predictors and outcome
A.C. Desbois, L. Biard, D Sene, I. Brocheriou, P. Rouvier, B. Lioger, L. Musset, S. Candon, T. Zenone, M. Resche-Rigon, J.C. Piette, N. Benameur, P. Cacoub, D. Saadoun
The Journal of Rheumatology Aug 2019, jrheum.190076; DOI: 10.3899/jrheum.190076